Read the full story by clicking on this headline.. |
The U.S. Food and Drug Administration on Thursday approved Amylyx Pharmaceuticals Inc's drug for slowing progression of ALS, or amyotrophic lateral sclerosis, and potentially delaying death. The Amylyx drug, to be sold under the brand name Relyvrio, is a combination of the... |
0 Comments
|
NewsMaxA conservative American news and opinion website founded by Christopher Ruddy in 1998 & operated by Newsmax Media. Archives
June 2023
Categories |